Risk of Gadolinium-Based Contrast Agents in Chronic Kidney Disease-Is Zero Good Enough?
Sign Up to like & getrecommendations! Published in 2019 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2019.5278
Abstract: In the 1990s and early 2000s, numerous patients with chronic kidney disease (CKD) were exposed to gadolinium-based contrast agents (GBCAs) for contrast-enhanced magnetic resonance imaging (MRI). At the time, the use of GBCAs was considered… read more here.
Keywords: risk; gbcas; contrast; group ... See more keywords
Standardized assessment of the signal intensity increase on unenhanced T1-weighted images in the brain: the European Gadolinium Retention Evaluation Consortium (GREC) Task Force position statement
Sign Up to like & getrecommendations! Published in 2018 at "European Radiology"
DOI: 10.1007/s00330-018-5803-6
Abstract: AbstractAfter the initial report in 2014 on T1-weighted (T1w) hyperintensity of deep brain nuclei following serial injections of linear gadolinium-based contrast agents (GBCAs), a multitude of studies on the potential of the marketed GBCAs to… read more here.
Keywords: methodology; gbcas; t1w hyperintensity; brain ... See more keywords
Fear of linear gadolinium-based contrast agents and the Japanese radiologist’s choice
Sign Up to like & getrecommendations! Published in 2017 at "Japanese Journal of Radiology"
DOI: 10.1007/s11604-017-0682-3
Abstract: The fear of using linear-type GBCAs has spread rapidly among Japanese radiologists since the first report suggesting a higher risk of deposition of linear-type GBCAs [1]. Moreover, according to the medical information and technology service… read more here.
Keywords: gbcas; fear; linear type; type gbcas ... See more keywords
Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Internal Medicine"
DOI: 10.7326/m20-0299
Abstract: BACKGROUND The risk for nephrogenic systemic fibrosis (NSF) after exposure to newer versus older gadolinium-based contrast agents (GBCAs) remains unclear. PURPOSE To synthesize evidence about NSF risk with newer versus older GBCAs across the spectrum… read more here.
Keywords: nsf; risk; exposure newer; kidney ... See more keywords